KEPICENE
Dead / Cancelled — Cancelled — Section 8 (as of 08 Jul 2011)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 76113885
- Registration number
- 2908931
- Mark type
- Word mark
- Filed
- 22 Aug 2000
- Published for opposition
- 05 Jun 2001
- Registered
- 07 Dec 2004
- Attorney of record
- Mark I. Feldman
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations used for the prevention and treatment of disorders involving the destruction, proliferation, repair and reconstruction of epithelial cells
Owner
- BIOVITRUM AB (PUBL), STOCKHOLM, SE
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 08 Jul 2011 — CANCELLED SEC. 8 (6-YR)
- 27 May 2009 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 07 Dec 2004 — REGISTERED-PRINCIPAL REGISTER
- 04 Oct 2004 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 24 Sept 2004 — ASSIGNED TO LIE
- 16 Sept 2004 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Sept 2004 — ASSIGNED TO EXAMINER
- 08 Sept 2004 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Aug 2004 — USE AMENDMENT FILED
- 27 Aug 2004 — TEAS STATEMENT OF USE RECEIVED
- 06 Jul 2004 — CASE FILE IN TICRS
- 27 Feb 2004 — SOU EXTENSION 5 GRANTED
- 18 Feb 2004 — SOU EXTENSION 5 FILED
- 18 Feb 2004 — SOU TEAS EXTENSION RECEIVED
- 23 Jul 2003 — SOU EXTENSION 4 GRANTED